Viewing Study NCT00884234


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-27 @ 12:08 PM
Study NCT ID: NCT00884234
Status: COMPLETED
Last Update Posted: 2020-08-28
First Post: 2009-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Sponsor: Revance Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module